|
DNAJC16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07611705604904E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.55915297234333E-12 |
| Normal-vs-Stage2 |
2.979616553489E-12 |
| Normal-vs-Stage3 |
3.33066907387547E-16 |
| Normal-vs-Stage4 |
1.62470037423645E-12 |
| Stage1-vs-Stage2 |
1.066840E-01 |
| Stage1-vs-Stage3 |
2.597300E-04 |
| Stage1-vs-Stage4 |
2.808900E-04 |
| Stage2-vs-Stage3 |
3.018800E-01 |
| Stage2-vs-Stage4 |
1.903650E-01 |
| Stage3-vs-Stage4 |
6.364200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.00870439673417E-14 |
| Normal-vs-AfricanAmerican |
4.9960036108132E-15 |
| Normal-vs-Asian |
2.141600E-02 |
| Caucasian-vs-AfricanAmerican |
1.281790E-01 |
| Caucasian-vs-Asian |
2.738000E-01 |
| AfricanAmerican-vs-Asian |
6.291800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
4.25609547605177E-11 |
| Male-vs-Female |
1.99369999998034E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59999791193854E-11 |
| Normal-vs-Age(41-60Yrs) |
1.87361237635741E-12 |
| Normal-vs-Age(61-80Yrs) |
8.54871728961371E-15 |
| Normal-vs-Age(81-100Yrs) |
8.17069999992093E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.920300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.079600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.158000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.749610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.490800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.510000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.866410E-02 |
| Normal-vs-Grade 2 |
1.26390009569377E-11 |
| Normal-vs-Grade 3 |
4.10782519111308E-15 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
1.120600E-01 |
| Grade 1-vs-Grade 3 |
5.840000E-03 |
| Grade 1-vs-Grade 4 |
7.72499999524001E-08 |
| Grade 2-vs-Grade 3 |
1.497350E-03 |
| Grade 2-vs-Grade 4 |
3.28315152842151E-12 |
| Grade 3-vs-Grade 4 |
2.19299999999478E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.36649999596494E-08 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.17350573702879E-13 |
| Normal-vs-N1 |
1.50580000002343E-06 |
| N0-vs-N1 |
2.104800E-01 |
|
|
